The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-cyclopropyl-6-fluoro-4-oxo-7-(4-((4-(N-pyrimidin-2-ylsulfamoyl)phenyl)diazenyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid ID: ALA5072607
PubChem CID: 166630765
Max Phase: Preclinical
Molecular Formula: C27H25FN8O5S
Molecular Weight: 592.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cn(C2CC2)c2cc(N3CCN(/N=N/c4ccc(S(=O)(=O)Nc5ncccn5)cc4)CC3)c(F)cc2c1=O
Standard InChI: InChI=1S/C27H25FN8O5S/c28-22-14-20-23(36(18-4-5-18)16-21(25(20)37)26(38)39)15-24(22)34-10-12-35(13-11-34)33-31-17-2-6-19(7-3-17)42(40,41)32-27-29-8-1-9-30-27/h1-3,6-9,14-16,18H,4-5,10-13H2,(H,38,39)(H,29,30,32)/b33-31+
Standard InChI Key: IYXZPIBXDPHISI-QOSDPKFLSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
19.8355 -7.4455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4310 -6.7398 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.0220 -7.4429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1045 -1.8613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1034 -2.6809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8114 -3.0898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8096 -1.4525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5182 -1.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5171 -2.6829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2272 -3.0943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9430 -2.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9442 -1.8598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2295 -1.4439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6529 -1.4529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3596 -1.8633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6549 -0.6357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2249 -3.9115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2296 -0.6267 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8180 -4.6181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6352 -4.6204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3967 -1.4529 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.3953 -3.0889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6916 -2.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9857 -3.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9809 -3.8974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6881 -4.3087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4002 -3.9025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2713 -4.3028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2676 -5.1199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5580 -5.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8560 -5.1108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1469 -5.5155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1427 -6.3335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8536 -6.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5597 -6.3382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7273 -6.3290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0177 -6.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3158 -6.3185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6066 -6.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6022 -7.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3129 -7.9529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0192 -7.5461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
12 14 1 0
14 15 1 0
14 16 2 0
10 17 1 0
13 18 2 0
19 17 1 0
20 19 1 0
17 20 1 0
4 21 1 0
5 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
33 2 1 0
2 36 1 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 37 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 592.61Molecular Weight (Monoisotopic): 592.1653AlogP: 3.59#Rotatable Bonds: 8Polar Surface Area: 162.45Molecular Species: ACIDHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 5.82CX Basic pKa: ┄CX LogP: 3.36CX LogD: 1.30Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.29Np Likeness Score: -1.31
References 1. Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH.. (2022) Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects., 228 [PMID:34871841 ] [10.1016/j.ejmech.2021.114021 ]